PiB-, florbetapir-PET yield same results for Alzheimer's diagnosis

01/9/2013 | HealthImaging.com

PET imaging of beta-amyloid levels using Pittsburgh compound B or florbetapir yielded consistent results, according to a study in the Journal of Nuclear Medicine. The two methods gave concordant beta-amyloid positive and negative status and comparable cortical retention ratios, the study found. "These analyses are an initial step in addressing the need for standardization of AB methodologies," researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC